Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1999-2006

  Rennert, Paul D ^a   Browning, Jeffrey L ^a   Mebius, Reina ^b   Mackay, Fabienne ^a   Hochman, Paula S ^a,c  

^a Biegen Inc   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL SURFACE; GENE DISRUPTION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RECEPTOR BINDING;

EID: 0029844961     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.5.1999     Document Type: Article

References (40)

1. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392-399.
2. Gruss, H.-J., and S.K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 85:3378-3404.
3. Browning, J.L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E.P. Chow, C. Hession, G.B. O'Brine, S.F. Foley, and C.F. Ware. 1993. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell. 72:847-856.
4. Browning, J.L., I. Dougas, A. Ngam-ek, P.R. Bourdon, B.N. Ehrenfels, K. Miatkowski, M. Zafari, A.M. Yampaglia, P. Lawton, W. Meier et al. 1995. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33-46.
5. Crowe, P., T.L. Van Arsdale, B.N. Walter, C.F. Ware, C. Hession, B. Ehrenfels, J.L. Browning, W.S. Din, R.G. Goodwin, and C.A. Smith. 1994. A lymphotoxin-β-specific receptor. Science (Wash. DC). 264:707-710.
6. Browning, J.L., K. Miatkowski, I. Sizing, D.A. Griffiths, M. Zafari, C.D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin-beta receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183: 867-878.
7. 6a. Hochman, P., G.R. Majeau, F. Mackay, and J.L. Browning. 1996. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric tymphotoxin ligands. J. Inflammation. 46:220-234.
8. Fiers, W. 1995. Biologic therapy with TNF: preclinical studies. In Biologic Therapy of Cancer. V. DeVita, S. Hellman, and S. Rosenberg, editors. J.B. Lippincott Co., Philadelphia, PA. 295-327.
9. Matsumoto, M., S. Mariathasan, M.H. Nahm, F. Baranyay, J.J. Peschon, and D.D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science (Wash. DC). 271:1289-1291.
10. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin alpha. Science (Wash. DC). 264:703-707.
11. Banks, T.A., B.T. Rouse, M.K. Kerley, P.J. Blair, V.L. Godfrey, N.A. Kuklin, D.M. Bouley, J. Thomas, S. Kanangat, and M.L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice: effects on secondary lymphoid development and humoral immune responsiveness. J. Immunol. 155:1685-1693.
12. Eugster, H.-P., M. Muller, U. Karrer, B.C. Car, B. Schnyder, V.M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, et al. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8:23-26.
13. Pfeffer, K., T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kranke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73: 457-467.
14. Erickson, S.L., F.J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K.C.F. Sheehan, R.D. Schreiber, D.V. Goeddel, and M. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature (Lond.). 372:560-563.
15. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (Lond.). 364:798-802.
16. Peppel, K., A. Poltorak, I. Melhado, F. Jirik, and B. Beutler. 1993. Expression of a TNF inhibitor in transgenic mice. J. Immunol. 151:5699-5703.
17. Neumann, B., A. Luz, K. Pfeffer, and B. Holzmann. 1996. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 184: 259-264.
18. Kratz, A., A. Campos-Neto, M.S. Hansen, and N.H. Ruddle. 1996. Chronic inflammation caused by lymphotoxin is lymphoid organogenesis. J. Exp. Med. 183:1461-1472.
19. Ahouse, J.J., C.L. Hagerman, P. Mittal, D.J. Gilbert, N.G. Copeland, N.A. Jenkins, and N.E. Simister. 1993. Mouse MHC class I-like Fc receptor encoded outside the MHC. J. Immunol. 151:6076-6088.
20. Force, W.R., B.N. Walter, C. Hession, R. Tizard, C.A. Kozak, J.L. Browning, and C.F. Ware. 1995. Mouse lymphotoxin-β receptor: molecular genetics, ligand binding, and expression. J. Immunol. 155:5280-5288.
21. Miller, G.T., P.S. Hochman, W. Meier, R. Tizard, S.A. Bixler, M.D. Rosa, and B.P. Wallner. 1993. Specific interaction of lymphocyte function associated antigen-3 with CD2 can inhibit T cell responses. J. Exp. Med. 178:211-222.
22. Eikelenhoon, P., J.J.J. Nassy, J. Post, J.C.M.B. Versteeg, and H.L. Langevoort. 1978. The histogenesis of LNs in rat and rabbit. Anat. Rec. 190:201-216.
23. Nakamura, T., K. Tashiro, M. Nazarea, T. Nakano, S. Sasayama, and T. Honjo. 1995. The murine lymphotoxin-β receptor cDNA: isolation by the signal sequence trap and chromosomal mapping. Genomics. 30:312-319.
24. 22a. Ettinger, R., J.L. Browning, S.A. Michie, W. Van Ewijk, and H.O. McDevitt. 1996. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 Fc chimeric fusion protein. Proc. Natl. Acad. Sci. USA. In press.
25. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T.W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587-1593.
26. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukocyte Biol. 45:97-104.
27. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429-434.
28. Koike, R., T. Nishimura, R. Yasumizu, H. Tanaka, Y. Hataba, T. Watanabe, S. Miyawaki, and M. Mayasaka. 1996. The splenic marginal zone is absent in alymphoplastic aly mutant mice. Eur. J. Immunol. 26:669-675.
29. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.). 373:531-536.
30. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of relB, a member of the NF-kappaB/rel family. Cell. 80:331-340.
31. Georgopoulos, K., M. Bigby, J.-H. Wang, A. Molnar, P. Wu, S. Winandy, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:143-156.
32. Roberts, C.W.M., J.R. Shutter, and S.J. Korsmeyer. 1994. Hox11 controls the genesis of the spleen. Nature (Lond.). 368: 747-749.
33. 30a. Murphy, M., L. Pike-Nobile, J.L. Browning, C.F. Ware and L.B. Epstein. 1995. Expression of lymphotoxin-β receptor in human thymus and spleen. Proc. Ninth Int. Cong. of Immunol. 770. (Abstr.)
34. Ware, C.F., T.L. van Arsdale, P.D. Crowe, and J.L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Current Topics Microbiol. Immunol. 198:175-218.
35. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: acivation, costimulation and death. Cell. 766:959-962.
36. Kooten, C.V., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
37. Han, S., K. Hathcock, B. Zheng, T. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers: roles of CD40-ligand and B7-2 in established germinal centers. J. Immunol. 155:556-567.
38. Worm, M., and R.S. Geha. 1994. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int. Immunol. 6:1883-1890.
39. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:389-399.
40. Yang, J.T., H. Rayburn, and R.O. Hynes. 1995. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development. 121:549-560.